In particular, TANs exhibited a higher Glut1 expression with a subsequently enhanced glucose uptake, whereas the neutrophil-specific deletion of solute carrier family 2 member 1 (Slc2a1), which encodes for Glut1, was found to be associated with a decreased TAN survival and limited tumor growth in mice [45]. The gene discussed is SLC2A1; the disease is neoplasm.